4Botfield C, Ross RJ,Hinds CJ. The role of IGFs in cataboli- sm. Baillieres Clin Endocrinol Metab, 1997,11(4): 679-697
5Rockich KT, Hatton JC, Kryscio RJ, et al. Effect of recombinant human growth hormone and insulin- like growth factor- 1 administration on IGF- 1 and IGF- binding protein- 3 levels in brain injury. Pharmacotherapy, 1999,19(12): 1432-1436
3Stephen B. The use of proton pump inhibitors for gastric acid sup- pression in critical illness. Critical Care,2005,9( 1 ) :45-50.
4Dieter S, Gunter H, Norbert S ,et 81. Low ropreva-lenee of helieo- baeter pylori infection in patients with stress ulcer bleeding. Iner- sive Care Medicine,2000,26(12):1832-1835.
5Faisy C, Guert E, Diehl JL, et al. Clinically significant gastrointesti- nal blooding in critically ill patients with and without stress ulcer prophylaxis. Intensine Care Medicine ,2003,29 ( 8 ) : 1308-1311.
6江明性,钱家庆,姚伟星,等.新编实用药物学.第2版.北京:科学出版社,2005:430.
7Jung R,Maelaren R. Proton-pump inhibitors for stress ulcer proph- ylaxis in critically ill patients. Ann Pharmacother,2002,36 (12) : 1929-1933.
8Hardy P, Johnston K M, de Beaumont L, et al. Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury. J Neurol Sci ,2007,253 ( 1/2 ) :94-105.